| Annual Financials | 2023 | 2024 | TTM |
Revenue  | 560 | 738 | 824 |
| Expenses | 337 | 454 | 520 |
| EBITDA | 223 | 284 | 304 |
| Operating Profit % | 39 % | 37 % | 35 % |
| Depreciation | 2 | 5 | 9 |
| Interest | 0 | 4 | 2 |
| Profit Before Tax | 219 | 247 | 293 |
| Tax | 54 | 66 | 76 |
| Net Profit | 165 | 181 | 218 |
| EPS in ₹ | 71.60 | 78.59 | 94.60 |
Sanofi Consumer Healthcare
Sanofi Consumer Healthcare
4,464.10
+64.60
(1.47%)
Market Cap
10,281.10 Cr
PE Ratio
46.40
Volume
2,316.00
Day High - Low
4,499.00 - 4,382.00
52W High-Low
5,894.50 - 4,380.20
Key Fundamentals
Market Cap
10,281.10 Cr
EPS
78.59
PE Ratio
46.40
PB Ratio
39.33
Book Value
111.60
EBITDA
283.60
Dividend Yield
1.25 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
66.30
Debt to Equity
0.04
Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
Sanofi Consumer Healthcare India Limited reported quarterly results for the period ended September 30, 2025. Revenue from operations reached ₹2,339 million, representing a 46% increase compared to the same quarter last year. Net profit for the quarter was ₹629 million, up 40% year-on-year. For the nine-month period, revenue grew 13% to ₹6,274 million, while profit after tax increased 27% to ₹1,736 million. Domestic sales grew 20% during the quarter, while export sales grew over 1000% from a low base. The company successfully relaunched all previously recalled products - Depura Adult and Combiflam Suspension were relaunched earlier in the year, while Allegra Suspension and Depura Kids were relaunched in the September quarter. The company operates in the pharmaceutical business segment with key brands including Allegra, DePURA, Avil and Combiflam. Managing Director Himanshu Bakshi noted that the results reflect strength in their diversified portfolio and sustained growth momentum.
Sanofi Consumer Healthcare India Shareholders Approve Material Related Party TransactionsOct 30, 2025
Sanofi Consumer Healthcare India Limited announced the results of its postal ballot process conducted through remote e-voting. Shareholders approved two ordinary resolutions for material related party transactions with overwhelming majority. The first resolution for approval of material related party transactions with Opella Healthcare India Private Limited received 99.8699% votes in favor and 0.1301% against. The second resolution for approval of material related party transactions with Opella Healthcare International SAS also received identical voting results of 99.8699% in favor and 0.1301% against. The postal ballot notice was dated August 4, 2025, with voting conducted from September 30, 2025 to October 29, 2025. Mr. Omkar Dindorkar from MMJB Associates LLP served as the scrutinizer for the voting process. The company has 51,137 total shareholders on record date, with National Securities Depository Limited providing the remote e-voting facility.
Sanofi Consumer Healthcare India Limited appointed Richard D'souza as Chief Financial Officer effective October 16, 2025. The appointment was approved by the Board of Directors based on recommendations from the Nomination and Remuneration Committee and in consultation with the Audit Committee. D'souza brings over 25 years of leadership experience in finance across multinational and listed organizations in FMCG and consumer goods sectors. He has expertise in financial strategy, M&A, investor relations, governance, and digital transformation. Previously, he served as Head of Finance at Bajaj Consumer Care, where he led acquisitions and strategic market expansion. He also worked with Castrol India managing treasury operations and ERP migrations. D'souza is a Chartered Accountant and Certified Information Systems Auditor.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,782.60 | #1 4,27,705.45 | 40.28 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 53.13 | |
6,642.50 | 1,76,337.50 | 70.98 | 9,712.00 | 18.67 | 2,191 | 35.10 | 63.15 | |
4,092.20 | 1,38,498.64 | 62.26 | 11,539.40 | 6.99 | 1,911 | 30.46 | 71.28 | |
1,467.90 | 1,18,572.82 | 22.75 | 28,409.50 | 7.12 | 5,291 | 3.71 | 57.84 | |
1,242.80 | 1,03,727.86 | #1 18.27 | 33,741.20 | 16.73 | 5,725 | -0.38 | 46.16 | |
2,214.30 | 1,01,148.96 | 22.61 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 63.46 | |
2,311.80 | 95,432.28 | 52.17 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 56.13 | |
927.55 | 93,333.23 | 18.63 | 23,511.00 | 18.55 | 4,615 | 34.60 | 54.52 | |
1,235.40 | 71,752.23 | 20.91 | 32,345.60 | 9.43 | 3,484 | 3.81 | 60.21 | |
5,806.50 | 69,425.42 | 28.04 | 13,458.30 | 3.70 | 2,216 | 10.98 | 55.49 |
Growth Rate
Revenue Growth
31.81 %
Net Income Growth
9.76 %
Cash Flow Change
1,09,850.00 %
ROE
-16.53 %
ROCE
-18.07 %
EBITDA Margin (Avg.)
-3.49 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 |
| Total Assets | 345 | 431 |
| Fixed Assets | 5 | 29 |
| Current Assets | 335 | 392 |
| Capital Work in Progress | 3 | 1 |
| Investments | 0 | 0 |
| Other Assets | 338 | 402 |
| Total Liabilities | 345 | 431 |
| Current Liabilities | 130 | 131 |
| Non Current Liabilities | 8 | 28 |
| Total Equity | 208 | 273 |
| Reserve & Surplus | 183 | 250 |
| Share Capital | 2 | 23 |
Cash Flow
| Cash Flow | 2023 | 2024 |
| Net Cash Flow | 2 | 325 |
| Investing Activities | 0 | 2 |
| Operating Activities | -0 | 439 |
| Financing Activities | 2 | -116 |
Share Holding
| % Holding | Jun 2024 | Sept 2024 | Oct 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 60.40 % | 60.40 % | 60.40 % | 60.40 % | 60.40 % | 71.27 % | 71.27 % |
| FIIs | 0.00 % | 5.22 % | 4.87 % | 4.42 % | 4.53 % | 3.24 % | 2.94 % |
| DIIs | 20.87 % | 24.03 % | 24.51 % | 25.35 % | 25.48 % | 16.89 % | 17.21 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 7.71 % | 7.53 % | 7.41 % | 7.01 % | 6.58 % | 6.30 % | 6.26 % |
| Others | 11.03 % | 2.83 % | 2.82 % | 2.83 % | 3.01 % | 2.30 % | 2.32 % |
| No of Share Holders | 61,091 | 61,091 | 57,598 | 55,734 | 51,859 | 49,632 | 48,808 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 55 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.14 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 4,864.05 | 4,911.45 |
| 20 Feb 2025 | Quarterly Result Announcement | NA | 20 Feb 2025 | 4,714.65 | 4,743.70 |
| 17 Apr 2025 |  Dividend | ₹ 55.00 /share | 17 Apr 2025 | 4,743.70 | 4,984.00 |
| 02 May 2025 | Quarterly Result Announcement | NA | 02 May 2025 | 4,940.10 | 4,942.35 |
| 05 May 2025 |  Annual General Meeting | NA | 05 May 2025 | 4,750.15 | 4,938.45 |
| 04 Aug 2025 | Quarterly Result Announcement | NA | 04 Aug 2025 | 4,968.40 | 4,864.10 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 4,874.40 | 4,601.65 |
Announcements
Closure of Trading Window
Dec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 12, 2025
Nov 12, 2025Results-Financial Results For September 30 2025Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday 12Th November 2025Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 30Th September 2025Nov 05, 2025
Nov 05, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotOct 30, 2025
Oct 30, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportOct 30, 2025
Oct 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 16, 2025
Oct 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Oct 10, 2025
Oct 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 30, 2025
Sep 30, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Aug 06, 2025Appointment Of Chief Financial Officer - Key Managerial PersonnelAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 04, 2025
Aug 04, 2025Outcome Of Board Meeting Held On Monday 4Th August 2025Aug 04, 2025
Aug 04, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 4Th August 2025Aug 04, 2025
Aug 04, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 4Th August 2025Aug 04, 2025
Aug 04, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2025Jul 29, 2025
Jul 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Disclosure Under Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Jun 13, 2025
Jun 13, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 13, 2025
Jun 13, 2025Post-Offer AdvertisementMay 24, 2025
May 24, 2025Updates on Open OfferMay 10, 2025
May 10, 2025Updates on Open OfferMay 09, 2025
May 09, 2025Updates on Open OfferMay 08, 2025
May 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportMay 07, 2025
May 07, 2025Updates on Open OfferMay 07, 2025
May 07, 2025Updates on Open OfferMay 06, 2025
May 06, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 03, 2025
May 03, 2025Updates on Open OfferMay 03, 2025
May 03, 2025Updates on Open OfferMay 03, 2025
May 03, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 02, 2025
May 02, 2025Board Meeting Outcome For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St March 2025May 02, 2025
May 02, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday 2Nd May 2025May 02, 2025
May 02, 2025Updates on Open OfferMay 02, 2025
May 02, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 01, 2025
May 01, 2025Updates on Open OfferApr 30, 2025
Apr 30, 2025Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St March 2025Apr 25, 2025
Apr 25, 2025Updates on Open OfferApr 24, 2025
Apr 24, 2025Corrigendum To The Annual Report For Financial Year 2024Apr 23, 2025
Apr 23, 2025Reg. 34 (1) Annual Report.Apr 23, 2025
Apr 23, 2025Letter of OfferApr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Apr 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 13, 2025
Apr 13, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 37.16
ATR(14)
Less Volatile 118.47
STOCH(9,6)
Neutral 38.04
STOCH RSI(14)
Neutral 56.91
MACD(12,26)
Bearish -4.47
ADX(14)
Weak Trend 11.02
UO(9)
Bearish 46.89
ROC(12)
Downtrend And Accelerating -4.79
WillR(14)
Oversold -93.34
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
